Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Rundekang Medical Tech is a Chinese biotechnology firm dedicated to the research, development, and commercialization of in vitro diagnostic (IVD) solutions. Headquartered in Beijing, the company produces a wide range of diagnostic reagents and automated instruments utilized in clinical chemistry, immunology, and molecular biology. Their portfolio includes kits for detecting infectious diseases, cardiac markers, and inflammatory indicators, catering to the needs of hospitals and diagnostic centers. Rundekang is recognized as a high-tech enterprise, leveraging advanced manufacturing capabilities to ensure high-quality medical testing standards. The company also provides technical support and integrated laboratory solutions to support healthcare providers in clinical decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Rundekang Medical Tech.